JOHN HORTON, M.B., CH.B., F.A.C.P.; KENNETH B. OLSEN, M.D., F.A.C.P.
To the editor: Muggia and Heinemann, in their excellent article, "Hypercalcemia Associated with Neoplastic Disease," Ann Intern Med 73:281-290, 1970, state that sex hormone therapy of patients with breast cancer developing hypercalcemia should be discontinued until a normal serum calcium level has been established. We believe that this measure is not necessary and that sex hormones may even be started in the face of hypercalcemia (1). Adequate hydration has been an excellent prophylactic measure.
HORTON J, OLSEN KB. Hypercalcemia in Cancer. Ann Intern Med. ;73:1047–1048. doi: 10.7326/0003-4819-73-6-1047
Download citation file:
Published: Ann Intern Med. 1970;73(6):1047-1048.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use